← Back to Search

Procedure

Endoscopic Ultrasound for Gastrointestinal Cancer

N/A
Recruiting
Led By Ji Young Bang, MD MPH
Research Sponsored by Orlando Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights
No Placebo-Only Group

Summary

"This trial is comparing the standard echoendoscope with a new device called the EndoSound Visual System to see which one is better at evaluating lesions in the gastrointestinal tract."

Who is the study for?
This trial is for individuals with conditions like pancreatic cancer, bile duct cancer, and various gastrointestinal tumors. Participants should be suitable candidates for an endoscopic ultrasound examination.
What is being tested?
The study is testing a new device called the EndoSound Visual System against the standard echoendoscope to see which is better at evaluating lesions in the gastrointestinal tract.
What are the potential side effects?
Potential side effects may include discomfort, minor bleeding or bruising from the procedure site, infection risk, and rare cases of more serious complications related to endoscopy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of successful completion of the requisite EUS examination
Secondary study objectives
Diagnostic accuracy of procured specimen
Diagnostic adequacy of procured specimen in cell block
Diagnostic adequacy of procured specimen on onsite evaluation
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: EndoSound Vision SystemActive Control1 Intervention
EndoSound Vision System will be used and EUS examination will be performed per standard of care.
Group II: Standard echoendoscopeActive Control1 Intervention
Standard echoendoscope will be used and EUS examination will be performed per standard of care.

Find a Location

Who is running the clinical trial?

Orlando Health, Inc.Lead Sponsor
31 Previous Clinical Trials
14,977 Total Patients Enrolled
2 Trials studying Pancreatic Cyst
2,100 Patients Enrolled for Pancreatic Cyst
Ji Young Bang, MD MPHPrincipal InvestigatorOrlando Health, Digestive Health Institute
5 Previous Clinical Trials
1,773 Total Patients Enrolled
1 Trials studying Pancreatic Cyst
600 Patients Enrolled for Pancreatic Cyst
~93 spots leftby Dec 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top